Sutro Biopharma STRO 深 沪
交易中 11-03 09:54:35 美东时间
1.065
-0.055
-4.91%
华盛通- 最 高1.12
- 今 开1.12
- 成交量 5.75万股
- 最 低 1.06
- 昨 收 1.12
- 总市值 8995.14万
- 52周最高 4.60
- 市盈率 静 --
- 换手率 0.07%
- 52周最低 0.5231
- 委 比 -74.89%
- 总股本 8446.14万
- 历史最高 28.30
- 量 比 3.04
- 振 幅 5.36%
- 历史最低 0.5231
- 每 手 1
- 风险率 0.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Two Seas Capital Expresses Enthusiasm for Core Scientific's Future Prospects
Issues Letter to Shareholders Highlighting Significant Upside Potential If Proposed Sale to CoreWeave Is Not Approved Urges Shareholders to Vote AGAINST the Ill-Advised Transaction on the GO...
10-28 20:30
What's Driving Beyond Meat's 11% After-Hours Drop?
Beyond Meat shares fell 11% after hours following a volatile rally sparked by ETF inclusion and short-selling activity.
10-23 13:50
Latest Beyond Meat Short-Seller? Martin Shkreli, Of Course
Martin Shkreli shorts Beyond Meat stock as it ripped higher Wednesday.
10-22 23:20
Beyond Meat shares rally in heavy volume trading
Shares of plant-based meat company Beyond Meat (NASDAQ:BYND) have nearly doubled in value by midday on Monday in heavy volume trading. BYND is up 83.6% at $1.19 by 1:05pm ET. The stock rose as much as...
10-21 01:10
Lifeway and Danone Sign Cooperation Agreement
New Independent Directors to be Added Stockholders' Agreement Litigation is Stayed Lifeway is Evaluating Capital Allocation Alternatives to Maximize Value Danone Will Not Vote or Deliver Co...
10-01 05:10
Sutro Biopharma Announces Major Organizational Restructuring
Sutro Biopharma ( ($STRO) ) has shared an update. On September 29, 2025, Sutro ...
09-30 05:49
Sutro Biopharma Reveals An Organizational Restructuring To Prioritize The Advancement Of Its Three ADC Programs And Research And Development Collaborations; The Restructuring, Is Expected To Extend The Company's Runway Into At Least Mid-2027; Restructuring To Result In Workforce Reduction Of One-Third Of Employees; Co. On Track To Advance STRO-004 Into Clinic This Year, With Initial Data Expected In 2026
SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc.
09-30 05:14
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones
Sutro Biopharma announced organizational restructuring to advance its ADC programs, extending cash runway into mid-2027. The restructuring will reduce workforce by ~1/3 but accelerate clinical data for STRO-004 and other ADCs. CEO Jane Chung emphasized prioritizing resources for impactful therapies and thanked employees for their contributions. The company targets transformative cancer treatments via optimized ADCs.
09-29 21:05
Trump Warns Of $15 Trillion Investment Cancellation, Mcconnell Compares Tariff Era To 1930s And More: This Week In Politics
Trump warns of a $15T investment pullout, McConnell draws 1930s parallels, Musk gets snubbed at the White House, and Cuban cautions about political fallout.
09-07 17:01
Market Highs And Attractive Setups Ahead
S&P pushes to records, AVGO shows AI demand is real… The market keeps press...
09-05 23:04
